Insulin thermostability in a real-world setting
Lancet Diabetes Endocrinol
.
2023 May;11(5):310-312.
doi: 10.1016/S2213-8587(23)00028-1.
Epub 2023 Mar 29.
Authors
Sanket Pendsey
1
,
Steven James
2
,
Timothy J Garrett
3
,
Anders Bay Nord
4
,
Sharad Pendsey
1
,
Daniel Malmodin
4
,
Göran Karlsson
5
,
Jayanthi Maniam
6
,
Mark A Atkinson
3
,
Gun Forsander
7
,
Graham D Ogle
8
Affiliations
1
Diabetes Research Education and Management Trust, Nagpur, India.
2
Life for a Child, Diabetes NSW & ACT, Sydney, NSW 2037, Australia; University of the Sunshine Coast, Petrie, QLD, Australia.
3
University of Florida, Gainesville, FL, USA.
4
University of Gothenburg, Gothenburg, Sweden.
5
University of Gothenburg, Gothenburg, Sweden; Science for Life Laboratory, Gothenburg, Sweden.
6
Life for a Child, Diabetes NSW & ACT, Sydney, NSW 2037, Australia.
7
University of Gothenburg, Gothenburg, Sweden; Queen Silvia Children's Hospital, Gothenburg, Sweden.
8
Life for a Child, Diabetes NSW & ACT, Sydney, NSW 2037, Australia. Electronic address: gogle@diabetesaustralia.com.au.
PMID:
37003280
DOI:
10.1016/S2213-8587(23)00028-1
No abstract available
Publication types
Letter
MeSH terms
Diabetes Mellitus, Type 2* / drug therapy
Humans
Hypoglycemic Agents / therapeutic use
Insulin* / therapeutic use
Substances
Insulin
Hypoglycemic Agents